MedPath

Feasibility Study of a Diary for Allogenic Hematopoietic Stem Cell Transplantation Patients and Families

Not Applicable
Completed
Conditions
Psychological Disorder
Hematopoietic/Lymphoid Cancer
Interventions
Behavioral: quality of life questionnaire
Registration Number
NCT04172818
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Brief Summary

Allogenic hematopoietic stem cell transplantation is a specific time during hematological disease management for the patients, theirs relatives and the healthcare team. This heavy treatment is most of the time the last possible curative therapy and could cause many side effects such as infectious diseases and graft versus host reaction. The protective isolation is also a source of physical and psychological isolation. Published studies reported depressive syndrome, anxiety symptoms and post-traumatic stress disorders for patients and their families. Since 10 years ago, diaries are used in intensive care unit to limit these symptoms after a coma. In analogy, the diary for the patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long terms consequences. The investigators want to evaluate the psychological impact of a diary on the patients hospitalized for allogenic hematopoetic stem cell transplantation and on their relatives.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • patient age > 18 years
  • patient hospitalized for an hematopoietic allogenic stem cell transplantation
  • patient agreeing to participate
Exclusion Criteria
  • patient not hospitalized for an hematopoietic allogenic stem cell transplantation

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Patients with diaryquality of life questionnaireEvaluation the psychological impact of a diary on the patients hospitalized for allogenic hematopoetic stem cell transplantation and on their relatives.
Primary Outcome Measures
NameTimeMethod
Measure of diary impact on patient quality of lifea year after transplantation

the diary for patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long term consequences.

Secondary Outcome Measures
NameTimeMethod
Measure of diary impact on health care team satisfactiona year after transplantation

the diary for patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long term consequences.

Measure of diary impact on patient relative quality of lifea year after transplantation

the diary for patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long term consequences.

Trial Locations

Locations (1)

CHU Amiens

🇫🇷

Amiens, France

© Copyright 2025. All Rights Reserved by MedPath